MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$159,393K
EPS
-$1.44
Unit: Thousand (K) dollars

Income Statement
2026-06-30
2026-03-31
2025-12-31
Research and development
48,665 41,484 29,416*
General and administrative
26,412 17,736 12,161*
Total operating expenses
75,077 59,220 41,577
Loss from operations
-75,077 -59,220 -41,577*
Interest income
3,587 3,457 2,740*
Interest expense
1,233 1,245 1,371*
Foreign exchange loss, net
-32 -44 -33*
Change in fair value of 2022 usd financing warrants
86,231 20,046 5,708*
Gain on extinguishment of contribution payable
--0*
Total other income/(expense)
-83,909 -17,878 -4,371*
Net loss
-158,986 -77,098 -45,948*
Unrealized gain/(loss) on investments
-406 -262 83*
Loss on foreign currency translation
-1 1 -16*
Comprehensive loss
-159,393 -77,359 -45,882
Basic EPS
-1.44 -0.71 -0.514
Diluted EPS
-1.44 -0.71 -0.514
Basic Average Shares
110,684,720 108,790,941 89,327,608
Diluted Average Shares
110,684,720 108,790,941 89,327,608
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$159,393K Net loss-$158,986K Unrealized gain/(loss) oninvestments-$406K Loss on foreigncurrency translation-$1K Total otherincome/(expense)-$83,909K Loss from operations-$75,077K Interest income$3,587K Change in fair value of2022 usd financing...$86,231K Total operatingexpenses$75,077K Interest expense$1,233K Foreign exchange loss,net-$32K Research and development$48,665K General andadministrative$26,412K

Definium Therapeutics, Inc. (DFTX)

Definium Therapeutics, Inc. (DFTX)